Who owns the MAGENTA CLINICAL TRIAL trademark?

The MAGENTA CLINICAL TRIAL trademark is owned by IGC Pharma IP, LLC.

What class is the MAGENTA CLINICAL TRIAL trademark registered in?

The MAGENTA CLINICAL TRIAL trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for MAGENTA CLINICAL TRIAL?

The USPTO serial number for MAGENTA CLINICAL TRIAL is 98895084.

What is the registration number for MAGENTA CLINICAL TRIAL?

MAGENTA CLINICAL TRIAL is registered under USPTO registration number 0.

MAG

USPTO Trademark Record

PENDING

MAGENTA CLINICAL TRIAL

SN 98895084·Reg 0·Filed Dec 10, 2024

Owner IGC Pharma IP, LLC

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

MAGENTA CLINICAL TRIAL (Serial No. 98895084), Registration No. 0, is a pending US trademark filed on Dec 10, 2024 by IGC Pharma IP, LLC. This trademark covers Class 042 (Scientific, technology & SaaS services).

Statement of Use due: November 11, 202643 days remaining

Mark Intelligence

MAGENTA CLINICAL TRIAL (Reg. #0) is a pending US trademark that was filed in 2024 and is currently under USPTO examination. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Dec 10, 2024

SERIAL

98895084

REG#

REGISTERED

Dec 31, 1969

Owner

Applicant

IGC Pharma IP, LLC

Entity

LLC

State

Address

10224 Falls Road, Potomac, MD, 20854

Country

Attorney

NameElizabeth P. West

Law firm

Elizabeth P. West Bay State IP, LLC

Docket

1024.814.IG

Address

50 Milk Street, 16th Floor, Boston, MA 02109, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusPENDING

Filing DateDec 10, 2024

Serial Number98895084

Registration No.0

Registration DateDec 31, 1969

Status DateMar 27, 2026

Published for OppositionSep 16, 2025

Mark TypeDesign with words

Attorney Docket1024.814.IG

Status DescriptionLive and pending, first extension granted

Filing Signals

FILED

2024

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

19 events

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 28, 2026

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Mar 27, 2026

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Mar 27, 2026

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Mar 27, 2026

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Nov 11, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Sep 16, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Sep 16, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Sep 10, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 13, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 11, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 11, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 11, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Jun 11, 2025

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Jun 11, 2025

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jun 11, 2025

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

May 29, 2025

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 20, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NOTICE OF DESIGN SEARCH CODE E-MAILED

May 20, 2025

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION ENTERED

Dec 10, 2024

NEW APPLICATION ENTERED

MAGENTA CLINICAL TRIAL

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by IGC Pharma IP, LLC

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Elizabeth P. West

Resources

Company